Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study
Gla-300 improved glycaemic control with a relatively low hypoglycaemia risk and minimal weight gain in Chinese people with T2D uncontrolled on previous BI.
Authors
- Hailin Shao (ORCID: https://orcid.org/0000-0003-3279-9542)
- Jie Han (ORCID: https://orcid.org/0009-0009-4193-6458)
- Minlu Zhang (ORCID: https://orcid.org/0000-0001-9044-3961)
- Caixian Yang
- Wensheng Yan (ORCID: https://orcid.org/0000-0001-6297-4589)
- Jianzhong Xiao (ORCID: https://orcid.org/0000-0001-8449-6346)
- Lei Kang (ORCID: https://orcid.org/0000-0001-8729-4547)
- Min Li (ORCID: https://orcid.org/0000-0001-8690-3451)
- Liming Chen (ORCID: https://orcid.org/0000-0002-5682-2340)
- Hailong Wan
- Jialin Li (ORCID: https://orcid.org/0000-0001-6930-9530)
- Yadong Sun
- Yanfang Han
Institutions
- Ningbo University (CN)
- Nankai University (CN)
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- People 's Hospital of Jilin Province (CN)
- Sanofi (China) (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Jiangjin Central Hospital (CN)
- Tianjin Medical University (CN)
- Guangzhou Medical University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1111/dom.16144
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Sanofi China Investment Company